Table 3 Pregnancy outcomes stratified by thyroid function and Autoantibody Status
Outcome | Euthyroid (n = 500) | Hypothyroid (n = 250) | Hyperthyroid (n = 150) | |||
|---|---|---|---|---|---|---|
Ab+ (n = 250) | Ab- (n = 250) | Ab+ (n = 125) | Ab- (n = 125) | Ab+ (n = 75) | Ab- (n = 75) | |
Fetal Outcomes | ||||||
Preterm birth | 21 (8.4%) | 15 (6.0%) | 18 (14.4%) | 14 (11.2%) | 8 (10.7%) | 7 (9.3%) |
Low birth weight | 18 (7.2%) | 13 (5.2%) | 16 (12.8%) | 12 (9.6%) | 7 (9.3%) | 5 (6.7%) |
NICU admission | 23 (9.2%) | 17 (6.8%) | 20 (16.0%) | 16 (12.8%) | 9 (12.0%) | 7 (9.3%) |
Low APGAR score | 17 (6.8%) | 12 (4.8%) | 14 (11.2%) | 11 (8.8%) | 7 (9.3%) | 5 (6.7%) |
Maternal Outcomes | ||||||
Preeclampsia | 19 (7.6%) | 13 (5.2%) | 25 (20.0%) | 21 (16.8%) | 7 (9.3%) | 5 (6.7%) |
Postpartum hemorrhage | 23 (9.2%) | 18 (7.2%) | 18 (14.4%) | 15 (12.0%) | 9 (12.0%) | 7 (9.3%) |
Gestational hypertension | 22 (8.8%) | 16 (6.4%) | 17 (13.6%) | 14 (11.2%) | 8 (10.7%) | 6 (8.0%) |
Postpartum thyroiditis | 13 (5.2%) | 5 (2.0%) | 11 (8.8%) | 4 (3.2%) | 7 (9.3%) | 3 (4.0%) |